Biosistemos - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 100,663 | 78,406 | 38,759 | 61,568 | 50,411 | 55,305 | 186,937 | 32,472 |
| Profit before tax | - | - | - | - | - | - | 38,357 | -2,057 |
| Net profit | 28,934 | 6,048 | -3,984 | 2,390 | 2,236 | 5,037 | 36,439 | -2,057 |
| Equity | 110,268 | 109,315 | 98,321 | 100,711 | 102,946 | 107,984 | 138,541 | 136,484 |
| Liabilities | 2,548 | 7,194 | 5,138 | 2,399 | 6,006 | 2,825 | 3,209 | 1,496 |
| Non-current assets | 30,329 | 25,279 | 55,391 | 45,308 | 39,809 | 28,790 | 17,770 | 8,850 |
| Current assets | 82,487 | 91,230 | 48,068 | 57,802 | 69,143 | 82,019 | 123,980 | 129,130 |
| Total assets | 112,816 | 116,509 | 103,459 | 103,110 | 108,952 | 110,809 | 141,750 | 137,980 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 7,526 | 4,012 | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | +312.5% | -22.1% | -50.6% | +58.8% | -18.1% | +9.7% | +238.0% | -82.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 25.6% | 5.2% | -3.9% | 2.3% | 2.1% | 4.5% | 25.7% | -1.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 26.2% | 5.5% | -4.1% | 2.4% | 2.2% | 4.7% | 26.3% | -1.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 28.7% | 7.7% | -10.3% | 3.9% | 4.4% | 9.1% | 19.5% | -6.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | 20.5% | -6.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 65,133 | 29,402 | 14,094 | 21,730 | 23,266 | 23,702 | 93,469 | 25,978 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biosistemos - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-05-20 | 259.73 |
| 2025-11-18 | 2025-12-14 | 0.01 |
| 2025-10-23 | 2025-11-16 | 0.01 |
| 2025-08-28 | 2025-08-29 | 12.76 |
| 2025-08-19 | 2025-08-21 | 12.76 |
| 2024-05-16 | 2024-06-06 | 0.10 |
| 2024-04-23 | 2024-05-12 | 0.10 |
| 2024-01-16 | 2024-01-18 | 85.61 |
Biosistemos - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biosistemos, UAB (code 166103653) is a Private Limited Liability Company operating in wholesale of wood, construction materials and sanitary equipment. In 2025, revenue declined to €32.5K from €186.9K in 2024 and €55.3K in 2023, showing a sharp contraction after a stronger 2024. The company reported a net loss of €2.1K in 2025, compared with net profit of €36.4K in 2024 and €5.0K in 2023. Profit margin moved from 19.5% in 2024 to -6.3% in 2025. Total assets stood at €138.0K in 2025, slightly below €141.8K a year earlier, while equity remained high at €136.5K and liabilities were only €1.5K. This resulted in an equity ratio of 98.9% and a very low debt-to-equity ratio of 0.01. Asset turnover was 0.24x, and both ROE and ROA were -1.5% in 2025. Revenue per employee was €32.5K, while profit per employee was -€2.1K.